ReviewDiscover oncology2026

Nivolumab and ipilimumab combination therapy for melanoma efficacy, safety and clinical integration in metastatic and adjuvant settings.

Rechner Afuh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.